Skip to main content
Screener/Healthcare/Biotechnology

ANAB — AnaptysBio, Inc.

NASDAQ
$58.47-1.04 (-1.75%)
Mid CapHealthcareLow Beta
$17.11
$73.30
$58.34
$60.49
EPS (TTM)$-1.08
P/E Ratio-138.84
Dividend Yield—
Market Cap$2.25B
Volume289K
Prev Close$59.51
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$25.6M-$52.9M$-1.8497.6%-206.9%
Q4 '25$108.2M$49.6M$1.58199.8%45.8%
Q3 '25$76.3M$15.1M$0.5258.8%19.8%
Q2 '25$22.3M-$38.6M$-1.34-69.9%-173.5%
Q1 '25$27.8M-$39.3M$-1.28-48.3%-141.6%
Q4 '24$43.1M-$21.8M$-0.771.2%-50.5%
Q3 '24$30.0M-$32.9M$-1.14-40.6%-109.4%
Q2 '24$11.0M-$46.7M$-1.71-282.8%-425.3%
Get Your Daily Market Recap